UNICA IRIS Institutional Research Information System

CARDIA, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 168.663
NA - Nord America 6.296
AS - Asia 3.180
SA - Sud America 450
AF - Africa 92
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 178.691
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 166.267
US - Stati Uniti d'America 6.176
SG - Singapore 1.188
CN - Cina 1.173
UA - Ucraina 546
SE - Svezia 487
DE - Germania 431
BR - Brasile 365
VN - Vietnam 272
FI - Finlandia 233
GB - Regno Unito 221
FR - Francia 189
IN - India 98
KR - Corea 87
HK - Hong Kong 81
NL - Olanda 80
CA - Canada 66
AT - Austria 33
BD - Bangladesh 31
IQ - Iraq 31
RU - Federazione Russa 31
PL - Polonia 29
MA - Marocco 28
PK - Pakistan 28
JP - Giappone 26
TR - Turchia 25
IR - Iran 24
AR - Argentina 22
MX - Messico 22
BE - Belgio 20
ES - Italia 20
PT - Portogallo 18
ID - Indonesia 17
CO - Colombia 16
VG - Isole Vergini Britanniche 16
ZA - Sudafrica 16
PH - Filippine 14
EC - Ecuador 13
IE - Irlanda 13
TN - Tunisia 12
EG - Egitto 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 10
AU - Australia 8
KE - Kenya 8
KG - Kirghizistan 8
IL - Israele 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
RO - Romania 6
TW - Taiwan 6
BO - Bolivia 5
HU - Ungheria 5
LT - Lituania 5
PY - Paraguay 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
MU - Mauritius 4
AL - Albania 3
ET - Etiopia 3
IS - Islanda 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
PS - Palestinian Territory 2
UY - Uruguay 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
LU - Lussemburgo 1
MM - Myanmar 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 178.688
Salva come PNG Salva come JPEG
Città #
Cagliari 161.945
Uta 3.107
Singapore 667
Ashburn 565
Chandler 494
Fairfield 429
Woodbridge 371
Dallas 342
San Jose 336
Nyköping 315
Boardman 302
Jacksonville 298
Ann Arbor 282
Houston 233
Beijing 209
Dearborn 208
Wilmington 200
Seattle 173
Helsinki 149
Los Angeles 145
Cambridge 134
New York 125
Santa Clara 114
Hefei 100
Shanghai 99
Lauterbourg 95
Nanjing 93
Seoul 84
The Dalles 82
Milan 78
Ho Chi Minh City 73
Hong Kong 68
Boston 65
Hanoi 60
Council Bluffs 53
Rome 51
Guangzhou 44
Buffalo 40
Nanchang 38
Munich 37
Toronto 36
Shenyang 35
Redwood City 33
São Paulo 31
Vienna 29
Orem 28
Changsha 27
Chicago 24
Parma 24
San Diego 23
Tokyo 23
Casablanca 22
Dong Ket 22
Tianjin 22
Verona 21
Hebei 20
Naples 20
Jinan 19
Amsterdam 18
Brussels 18
Jiaxing 18
La Puente 18
Nürnberg 18
Redondo Beach 18
Frankfurt am Main 17
Chennai 16
Road Town 16
Sassari 16
Florence 15
London 15
Haiphong 14
Orange 14
Denver 13
Montreal 13
Mountain View 13
Norwalk 13
Warsaw 13
Atlanta 12
Auburn Hills 12
Padova 12
Turin 12
Baghdad 11
Brooklyn 11
Catania 11
Johannesburg 11
Nuremberg 11
Stockholm 11
Turku 11
Bologna 10
Dublin 10
Hangzhou 10
Rende 10
Rio de Janeiro 10
Augusta 9
Bari 9
Kunming 9
Lodz 9
Washington 9
Zhengzhou 9
Bishkek 8
Totale 173.295
Salva come PNG Salva come JPEG
Nome #
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs 4.602
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.600
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.316
Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems 3.922
Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging 3.889
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.772
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.514
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.490
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.477
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.455
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.335
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.278
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 3.275
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 3.256
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.214
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 3.015
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.970
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.822
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.785
null 2.749
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.607
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.606
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.525
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.450
1H NMR study of the interaction of trans-resveratrol with soybean phosphatidylcholine liposomes 2.408
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.385
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.345
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.310
New promising scaffolds for the inhibition of monoamine oxidase B 2.300
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.289
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.255
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.179
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.144
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 2.140
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.104
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.068
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 2.039
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.962
null 1.949
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.926
Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery 1.924
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.921
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.876
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.862
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.805
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.699
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.678
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.662
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.652
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.640
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.610
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.595
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.468
Transcutol® p containing slns for improving 8-methoxypsoralen skin delivery 1.450
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.423
null 1.415
null 1.406
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.186
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 1.141
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.126
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.106
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and DFT calculations. Investigation on a case of very remote Hammett correlation 1.099
Proniosomal formulation encapsulating pomegranate peel extract for nutraceutical applications 1.042
Progettazione e sintesi di 4-(5-ariliden-3-metil-4-ossotiazolidin-2-ilidenamino)benzensulfonamidi e 4-(5-alchiliden-3-metil-4-ossotiazolidin-2-ilidenammino)benzensulfonamidi quali potenziali inibitori selettivi delle ciclossigenasi 2 1.039
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.034
Computational approaches for discovery and optimization of monoamine oxidase B inhibitors 1.024
Pulmonary delivery of curcumin and beclomethasone dipropionate in a multicomponent nanosuspension for the treatment of bronchial asthma 985
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 974
1-benzenesulfonamide-1(H)-pyrazoles and 3-benzenesulfonamide-4-tiazolidinones, two promising scaffolds for the design of cycloxygenase inhibitors 965
null 943
CoMFA studies of non-covalent monoamine oxidase inhibitors 936
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 934
Combining induced fit docking and molecular dynamics simulations to predict the binding mode of new monoamine oxidase B inhibitors 919
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 909
Sintesi di cicloalchilidenidrazo-4-ariltiazoli ad elevata attività inibitrice selettiva sulla isoforma B delle monoammino ossidasi 902
1-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole; a new scaffold for monoaminoxidase inhibitors: design, synthesis, and biological properties 899
Computational and experimental study of non-covalent monoamine oxidase inhibitors 881
Novel MAO-B selective inhibitors developed using computational methods 860
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives 852
Topoisomerase I: synthesis of a new class of potential inhibitors 826
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 821
null 818
Impact of solid lipid nanoparticles on 3T3 fibroblasts viability and lipid profile: The effect of curcumin and resveratrol loading 800
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 763
null 735
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 699
null 693
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 686
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent 663
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 654
null 617
null 610
Synthesis of new arylidencycloalkylpyrazoles of biological interest 602
Bentonite- and Palygorskite-Based Gels for Topical Drug Delivery Applications 542
Isonicotinoylhydrazothiazoles and isonicotinoyl-N-4-substituted thiosemicarbazides: Synthesis, characterization, and anti-mycobacterial activity 492
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very remote Hammett correlation 481
Clay-Based Hydrogels as Drug Delivery Vehicles of Curcumin Nanocrystals for Topical Application 447
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives 406
New cycloalkylpyrazoles as potential cyclooxygenase inhibitors 391
Production of liposomes by microfluidics: The impact of post-manufacturing dilution on drug encapsulation and lipid loss 315
Totale 177.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.000
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.938 0 0 0 0 0 0 0 0 0 2.327 2.291 1.320
2021/20227.147 991 765 320 378 597 490 481 334 590 590 805 806
2022/202312.131 945 1.574 1.399 1.156 816 1.103 753 965 670 997 1.198 555
2023/202413.892 494 654 1.153 916 1.496 2.115 2.025 1.026 819 715 1.134 1.345
2024/202522.055 3.608 4.952 5.648 2.362 1.250 1.438 1.603 154 255 209 239 337
2025/20266.487 476 292 774 630 487 536 1.112 716 636 828 0 0
Totale 178.928